Everyone who reads this board has seen those data, and they do not help in making the point you are trying to make about AMR-101 being more valuable because the AIM-HIGH study failed.
I have a strong suspicion that, if the AIM-HIGH study had been a rip-roaring success, you would have posted that that was bullish for AMRN.
Market Data 
Markets 
AI
